Results 11 to 20 of about 3,066 (203)

Suppression of an accessory and cavitated uterine mass with norethindrone: a case report [PDF]

open access: yesF&S Reports
Objective: To describe conservative management for accessory and cavitated uterine mass (ACUM) with norethindrone acetate. The patient gave signed written, informed consent authorizing publication.
Hope Knochenhauer, M.D.   +2 more
doaj   +3 more sources

Norethindrone Acetate in the Medical Management of Adenomyosis

open access: yesPharmaceuticals, 2012
The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27–49 years of age presenting with moderate to severe pelvic pain and bleeding.
Özgül Muneyyirci-Delale
exaly   +4 more sources

Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents

open access: yesInternational Journal of Women's Health
Essam R Othman,1,2 Ayman Al-Hendy,3 Radwa Mostafa,1 Cornelis B Lambalk,2 Velja Mijatovic2 1OB-GYN Department, Assiut University, Assiut, 71515, Egypt; 2Academic Endometriosis Center, Amsterdam University Medical Center, Vrije Universiteit Amsterdam ...
Ayman Al-Hendy   +2 more
exaly   +3 more sources

Norethindrone

open access: yes, 2006
James L. Schardein, Orest T. Macina
europepmc   +5 more sources

Risks of pelvic inflammatory disease and bacterial vaginosis in adenomyosis patients using levonorgestrel intrauterine device or oral norethindrone [PDF]

open access: yesFrontiers in Endocrinology
BackgroundPatients with adenomyosis frequently experience menorrhagia and dysmenorrhea. Levonorgestrel-releasing intrauterine device (LNG-IUD) and oral norethindrone are widely used non-surgical treatment options.
Szu-Yun Niu   +6 more
doaj   +2 more sources

Norethindrone substituted for megestrol in the treatment of metastatic endometrial carcinoma: Three cases

open access: yesGynecologic Oncology Reports, 2017
Megestrol is an effective palliative treatment for endometrial carcinoma. Some persons with progestin-responsive cancer continue on hormonal therapy for months or even years.
William L. Read   +2 more
doaj   +2 more sources

Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy [PDF]

open access: yesCase Reports in Obstetrics and Gynecology, 2016
Erythema nodosum is a septal panniculitis that typically presents as symmetric, tender nodules on the anterior aspects of bilateral lower extremities.
Michelle S. Min   +2 more
doaj   +2 more sources

A Matched Case-Control Study Examining the Association Between Exposure to Depot Medroxyprogesterone Acetate and Cerebral Meningioma Using an Active Comparator [PDF]

open access: yesCurrent Oncology
The recent literature has reported an increased association between the use of depot medroxyprogesterone acetate (dMPA) and cerebral meningioma (CM). Prior studies have been limited in generalizability and did not use an active comparator as a control ...
Russell Griffin, Rebecca Arend
doaj   +2 more sources

Venous thromboembolism in obese hormonal contraceptive users: a large national database study [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis
Objectives: This study aimed to assess the risk of venous thromboembolism (VTE) among obese and nonobese females aged 10 to 44 years prescribed hormonal therapy (HT) and compare VTE rates between different HT types in a large national database.
Divyaswathi Citla-Sridhar   +5 more
doaj   +2 more sources

RETRACTED ARTICLE: Management of uterine leiomyoma and adenomyosis: role of hysteroscopy in diagnosis and norethindrone in the treatment

open access: yesScientific Reports
Abnormal uterine bleeding (AUB) represents a notable sign for benign and malignant uterine pathology. Differentiating adenomyosis from leiomyoma via hysteroscopy aids in selecting appropriate surgical or medical management.
Ahmed Ali   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy